LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q3 2020 Portfolio Holders as of 9/30/2020

Type / Class
Equity / COM NEW
Number of holders
246
Total Shares
22.7 M
Shares change
+775 K
Total reported value, excl. options
$2.16 B
Value change
+$67.3 M
Put/Call ratio
10.48
Number of buys
115
Number of sells
-133
Price
$95.32
CUSIP
53220K504
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.